Published in Blood Weekly, April 26th, 2001
Previously, stem cells for tissue engineering research had been harvested from bone marrow, brain, and fetal tissue: limited sources that pose a variety of logistical and ethical challenges. The availability of the plentiful source of stem cells will accelerate development of new procedures for repairing and replacing damaged, dead, or missing tissue in people.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.